These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 35866199)

  • 1. Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.
    Krieger NS; Asplin J; Granja I; Chen L; Spataru D; Wu TT; Grynpas M; Bushinsky DA
    Kidney Int; 2021 May; 99(5):1118-1126. PubMed ID: 33417997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate primarily inhibits the formation of calcium-oxalate kidney stones rather than dissolving them.
    Wang G; Huang Z; Gao H; Li J
    Asian J Surg; 2024 Jul; 47(7):3394-3396. PubMed ID: 38599963
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical versus Over-the-Counter Potassium Citrate: A Benchtop Comparison.
    Wong DG; Elson L; Nottingham CU; Desai AC
    Urol Pract; 2022 May; 9(3):205-211. PubMed ID: 37145541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney Stone Prevention: Is There a Role for Complementary and Alternative Medicine?
    Cupisti A; Giannese D; D'Alessandro C; Benedetti A; Panichi V; Alfieri C; Castellano G; Messa P
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rocky Discontinuation of Diet Mountain Dew.
    Durland J; Schumann SO
    J Investig Med High Impact Case Rep; 2022; 10():23247096221114518. PubMed ID: 35866199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis.
    Haleblian GE; Leitao VA; Pierre SA; Robinson MR; Albala DM; Ribeiro AA; Preminger GM
    J Endourol; 2008 Jun; 22(6):1359-66. PubMed ID: 18578663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies.
    Toews I; Lohner S; Küllenberg de Gaudry D; Sommer H; Meerpohl JJ
    BMJ; 2019 Jan; 364():k4718. PubMed ID: 30602577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diet orange soda on urinary lithogenicity.
    Sumorok NT; Asplin JR; Eisner BH; Stoller ML; Goldfarb DS
    Urol Res; 2012 Jun; 40(3):237-41. PubMed ID: 21858427
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.